Examining the treatment gap and risk of subsequent fractures among females with a fragility fracture in the US Medicare population.

ABSTRACT: Our aim was to evaluate the gap in osteoporosis treatment and the impact of osteoporosis treatment on subsequent fragility fractures. We found osteoporosis medication use lowered risk of subsequent fractures by 21% and that black race, higher CCI scores, dementia, and kidney diseases reduced the likelihood of osteoporosis medication use. INTRODUCTION:The goal of this study was to evaluate the predictors of osteoporosis medication use and compare the risk of fragility fractures within 1 year of a fragility fracture between osteoporosis treated and untreated women. METHODS:We conducted a retrospective, observational cohort study using the national Medicare database. Elderly women (≥65 years) who were hospitalized or had an outpatient/ER service for fragility fracture between January 1, 2011

SUBMITTER: Keshishian A 

PROVIDER: S-EPMC5524851 | biostudies-literature | 2017 Aug

REPOSITORIES: biostudies-literature